AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Elicio Therapeutics, Inc. Director's Dealing 2021

Aug 23, 2021

33784_dirs_2021-08-23_cb855c3b-5143-41fd-a600-97a1de9eda4c.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Angion Biomedica Corp. (ANGN)
CIK: 0001601485
Period of Report: 2021-02-04

Reporting Person: EISA-ABC LLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3654637	Direct